The Chilean Nuclear Energy Commission (CCHEN) is formulating a research and development (R & D) project aimed at developing a radiopharmaceutical for the detection of prostate cancer.
The proposal, which will be presented to the Corfo Crea and Valida contest for its co-financing, allows for the intervention of an investor or collaborator entity that is involved in achieving the results of said project.
Review requirements and conditions here.
